{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T15:35:39Z","timestamp":1782401739561,"version":"3.54.5"},"reference-count":89,"publisher":"SAGE Publications","issue":"1","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100017147","name":"International Progressive MS Alliance","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017147","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Mult Scler"],"published-print":{"date-parts":[[2022,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Progressive forms of multiple sclerosis (MS) affect more than 1 million individuals globally. Recent approvals of ocrelizumab for primary progressive MS and siponimod for active secondary progressive MS have opened the therapeutic door, though results from early trials of neuroprotective agents have been mixed. The recent introduction of the term \u2018active\u2019 secondary progressive MS into the therapeutic lexicon has introduced potential confusion to disease description and thereby clinical management.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>This paper reviews recent progress, highlights continued knowledge and proposes, on behalf of the International Progressive MS Alliance, a global research strategy for progressive MS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Literature searches of PubMed between 2015 and May, 2021 were conducted using the search terms \u201cprogressive multiple sclerosis\u201d, \u201cprimary progressive multiple sclerosis\u201d, \u201csecondary progressive MS\u201d. Proposed strategies were developed through a series of in-person and virtual meetings of the International Progressive MS Alliance Scientific Steering Committee.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Sustaining and accelerating progress will require greater understanding of underlying mechanisms, identification of potential therapeutic targets, biomarker discovery and validation, and conduct of clinical trials with improved trial design. Encouraging developments in symptomatic and rehabilitative interventions are starting to address ongoing challenges experienced by people with progressive MS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>We need to manage these challenges and realise the opportunities in the context of a global research strategy, which will improve quality of life for people with progressive MS.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/13524585211059766","type":"journal-article","created":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T05:41:52Z","timestamp":1638337312000},"page":"16-28","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":14,"title":["Charting a global research strategy for progressive MS\u2014An international progressive MS Alliance proposal"],"prefix":"10.1177","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4333-8496","authenticated-orcid":false,"given":"Alan J","family":"Thompson","sequence":"first","affiliation":[{"name":"University College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5088-548X","authenticated-orcid":false,"given":"William","family":"Carroll","sequence":"additional","affiliation":[{"name":"The University of Western Australia, Perth, WA, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Ciccarelli","sequence":"additional","affiliation":[{"name":"University College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giancarlo","family":"Comi","sequence":"additional","affiliation":[{"name":"Vita-Salute San Raffaele University, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0829-7569","authenticated-orcid":false,"given":"Anne","family":"Cross","sequence":"additional","affiliation":[{"name":"Washington University in St. Louis, St. Louis, MO, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexis","family":"Donnelly","sequence":"additional","affiliation":[{"name":"International Progressive MS Alliance, Dublin, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0132-0909","authenticated-orcid":false,"given":"Anthony","family":"Feinstein","sequence":"additional","affiliation":[{"name":"Sunnybrook Research Institute, Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4263-3717","authenticated-orcid":false,"given":"Robert J","family":"Fox","sequence":"additional","affiliation":[{"name":"Cleveland Clinic, Cleveland, OH, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Helme","sequence":"additional","affiliation":[{"name":"MS International Federation, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reinhard","family":"Hohlfeld","sequence":"additional","affiliation":[{"name":"Munich Cluster for Systems Neurology, Ludwig Maximilian University of Munich, Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Hyde","sequence":"additional","affiliation":[{"name":"Biogen, Cambridge, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela","family":"Kanellis","sequence":"additional","affiliation":[{"name":"MS Society of Canada, Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas","family":"Landsman","sequence":"additional","affiliation":[{"name":"National Multiple Sclerosis Society, New York, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Lubetzki","sequence":"additional","affiliation":[{"name":"Salp\u00eatri\u00e8re Hospital, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1855-5595","authenticated-orcid":false,"given":"Ruth Ann","family":"Marrie","sequence":"additional","affiliation":[{"name":"University of Manitoba, Winnipeg, MB, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Morahan","sequence":"additional","affiliation":[{"name":"MS Research Australia, North Sydney, NSW, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Montalban","sequence":"additional","affiliation":[{"name":"Hospital Vall d\u2019Hebron, Universitat Aut\u00f2noma de Barcelona, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Musch","sequence":"additional","affiliation":[{"name":"Genentech, San Francisco, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Rawlings","sequence":"additional","affiliation":[{"name":"MS Society, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0501-8803","authenticated-orcid":false,"given":"Marco","family":"Salvetti","sequence":"additional","affiliation":[{"name":"Department of Neurosciences, Mental Health and Sensory Organs, Centre for Experimental Neurological Therapies (CENTERS), Sapienza University of Rome, Rome, Italy\/Istituto Neurologico Mediterraneo (INM) Neuromed, Pozzilli, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Finn","family":"Sellebjerg","sequence":"additional","affiliation":[{"name":"Copenhagen University Hospital\u2014Rigshospitalet, Glostrup, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Sincock","sequence":"additional","affiliation":[{"name":"International Progressive MS Alliance, Glasgow, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn E","family":"Smith","sequence":"additional","affiliation":[{"name":"International Progressive MS Alliance, Lyme, CT, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon","family":"Strum","sequence":"additional","affiliation":[{"name":"International Progressive MS Alliance, Los Angeles, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Zaratin","sequence":"additional","affiliation":[{"name":"Italian Multiple Sclerosis Foundation, Genoa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3031-7549","authenticated-orcid":false,"given":"Timothy","family":"Coetzee","sequence":"additional","affiliation":[{"name":"National Multiple Sclerosis Society, New York, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2021,12,1]]},"reference":[{"key":"bibr1-13524585211059766","doi-asserted-by":"publisher","DOI":"10.1177\/1352458520970841"},{"key":"bibr2-13524585211059766","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awq118"},{"key":"bibr3-13524585211059766","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200011163432001"},{"key":"bibr4-13524585211059766","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/112.1.133"},{"key":"bibr5-13524585211059766","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)31320-4"},{"key":"bibr6-13524585211059766","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.26858"},{"key":"bibr7-13524585211059766","doi-asserted-by":"publisher","DOI":"10.1177\/1352458512458169"},{"key":"bibr8-13524585211059766","unstructured":"US Food and Drug Administration. FDA approves new drug to treat multiple sclerosis, 2017, https:\/\/www.fda.gov\/newsevents\/newsroom\/pressannouncements\/ucm549325.htm (accessed 11 August 2017)."},{"key":"bibr9-13524585211059766","unstructured":"Novartis. Novartis receives FDA approval for Mayzent\u00ae (siponimod), the first oral drug to treat secondary progressive MS with active disease, 2019, https:\/\/www.prnewswire.com\/news-releases\/novartis-receives-fda-approval-for-mayzent-siponimod-the-first-oral-drug-to-treat-secondary-progressive-ms-with-active-disease-300819243.html (accessed 16 April 2021)."},{"key":"bibr10-13524585211059766","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2018.20588"},{"key":"bibr11-13524585211059766","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2020.2453"},{"key":"bibr12-13524585211059766","doi-asserted-by":"publisher","DOI":"10.1038\/s41582-020-00421-4"},{"key":"bibr13-13524585211059766","doi-asserted-by":"publisher","DOI":"10.1016\/j.tips.2016.07.005"},{"key":"bibr14-13524585211059766","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000000560"},{"key":"bibr15-13524585211059766","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000009636"},{"key":"bibr16-13524585211059766","doi-asserted-by":"publisher","DOI":"10.1177\/1352458520975323"},{"key":"bibr17-13524585211059766","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/aww173"},{"key":"bibr18-13524585211059766","doi-asserted-by":"publisher","DOI":"10.1002\/ana.25592"},{"key":"bibr19-13524585211059766","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000000959"},{"key":"bibr20-13524585211059766","doi-asserted-by":"publisher","DOI":"10.1177\/1352458517703193"},{"key":"bibr21-13524585211059766","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awy088"},{"key":"bibr22-13524585211059766","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.03116"},{"key":"bibr23-13524585211059766","doi-asserted-by":"publisher","DOI":"10.1002\/ana.25197"},{"key":"bibr24-13524585211059766","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000001587"},{"key":"bibr25-13524585211059766","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-020-0885-1"},{"key":"bibr26-13524585211059766","doi-asserted-by":"publisher","DOI":"10.1097\/WCO.0000000000000818"},{"key":"bibr27-13524585211059766","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1615413114"},{"key":"bibr28-13524585211059766","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-018-0119-x"},{"key":"bibr29-13524585211059766","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2018.12.012"},{"key":"bibr30-13524585211059766","doi-asserted-by":"publisher","DOI":"10.1038\/nature21029"},{"key":"bibr31-13524585211059766","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awaa117"},{"key":"bibr32-13524585211059766","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awaa436"},{"key":"bibr33-13524585211059766","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awaa084"},{"key":"bibr34-13524585211059766","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awy338"},{"key":"bibr35-13524585211059766","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1404-z"},{"key":"bibr36-13524585211059766","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awz188"},{"key":"bibr37-13524585211059766","doi-asserted-by":"publisher","DOI":"10.1177\/1352458519900971"},{"key":"bibr38-13524585211059766","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000005685"},{"key":"bibr39-13524585211059766","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awz212"},{"key":"bibr40-13524585211059766","doi-asserted-by":"publisher","DOI":"10.1002\/ana.25145"},{"key":"bibr41-13524585211059766","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000008198"},{"key":"bibr42-13524585211059766","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000011314"},{"key":"bibr43-13524585211059766","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1803583"},{"key":"bibr44-13524585211059766","doi-asserted-by":"publisher","DOI":"10.3174\/ajnr.A6809"},{"key":"bibr45-13524585211059766","doi-asserted-by":"publisher","DOI":"10.1177\/1352458517707265"},{"key":"bibr46-13524585211059766","doi-asserted-by":"publisher","DOI":"10.1002\/ana.25738"},{"key":"bibr47-13524585211059766","doi-asserted-by":"publisher","DOI":"10.1177\/1352458520986956"},{"key":"bibr48-13524585211059766","doi-asserted-by":"publisher","DOI":"10.1002\/acn3.795"},{"key":"bibr49-13524585211059766","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000007032"},{"key":"bibr50-13524585211059766","doi-asserted-by":"publisher","DOI":"10.1177\/1352458518765666"},{"key":"bibr51-13524585211059766","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000009571"},{"key":"bibr52-13524585211059766","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000010346"},{"key":"bibr53-13524585211059766","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000012752"},{"key":"bibr54-13524585211059766","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1606468"},{"key":"bibr55-13524585211059766","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)30475-6"},{"key":"bibr56-13524585211059766","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(20)30347-1"},{"key":"bibr57-13524585211059766","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(18)30069-3"},{"key":"bibr58-13524585211059766","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)01314-8"},{"key":"bibr59-13524585211059766","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(19)30485-5"},{"key":"bibr60-13524585211059766","doi-asserted-by":"publisher","DOI":"10.1177\/1352458519843051"},{"key":"bibr61-13524585211059766","doi-asserted-by":"publisher","DOI":"10.1177\/1352458520974936"},{"key":"bibr62-13524585211059766","doi-asserted-by":"publisher","DOI":"10.1177\/1352458521999970"},{"key":"bibr63-13524585211059766","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(19)30190-5"},{"key":"bibr64-13524585211059766","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2018-320050"},{"key":"bibr65-13524585211059766","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000011241"},{"key":"bibr66-13524585211059766","doi-asserted-by":"publisher","DOI":"10.1177\/1352458520973619"},{"key":"bibr67-13524585211059766","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-020-01772-7"},{"key":"bibr68-13524585211059766","doi-asserted-by":"publisher","DOI":"10.1038\/s41582-020-00446-9"},{"key":"bibr69-13524585211059766","doi-asserted-by":"publisher","DOI":"10.1038\/nrneurol.2017.171"},{"key":"bibr70-13524585211059766","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2018-021944"},{"key":"bibr71-13524585211059766","unstructured":"UK MS society. Full steam ahead with our \u201cmega-trial\u201d for progressive MS, 2021, https:\/\/www.mssociety.org.uk\/research\/explore-our-research\/research-we-fund\/search-our-research-projects\/octopus (accessed April 16 2021)."},{"key":"bibr72-13524585211059766","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000011863"},{"key":"bibr73-13524585211059766","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000011862"},{"key":"bibr74-13524585211059766","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)62242-4"},{"key":"bibr75-13524585211059766","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000003653"},{"key":"bibr76-13524585211059766","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000006810"},{"key":"bibr77-13524585211059766","doi-asserted-by":"publisher","DOI":"10.1177\/1352458517723718"},{"key":"bibr78-13524585211059766","unstructured":"Patient Reported Outcomes for MS (PROMS) Consortium. European Charcot Foundation, https:\/\/www.charcot-ms.org\/initiatives\/proms#:~:text=Patient%20Reported%20Outcomes%20for%20MS,the%20design%20of%20healthcare%20systems."},{"key":"bibr79-13524585211059766","doi-asserted-by":"publisher","DOI":"10.1097\/WCO.0000000000000821"},{"key":"bibr80-13524585211059766","doi-asserted-by":"publisher","DOI":"10.1177\/1352458516638941"},{"key":"bibr81-13524585211059766","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(19)30357-6"},{"key":"bibr82-13524585211059766","doi-asserted-by":"publisher","DOI":"10.1177\/13524585211028561"},{"key":"bibr83-13524585211059766","doi-asserted-by":"publisher","DOI":"10.1177\/1352458519888178"},{"key":"bibr84-13524585211059766","doi-asserted-by":"publisher","DOI":"10.1038\/nrneurol.2017.184"},{"key":"bibr85-13524585211059766","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmed.2018.03.001"},{"key":"bibr86-13524585211059766","unstructured":"Multi\u2014ACT\u2014a collective research impact framework, http:\/\/multiact.eu (accessed 20 March 2021)."},{"key":"bibr87-13524585211059766","doi-asserted-by":"publisher","DOI":"10.1186\/s40359-015-0089-9"},{"key":"bibr88-13524585211059766","unstructured":"US Department of Veterans Affairs. QUERI\u2014quality enhancement research initiative, https:\/\/www.queri.research.va.gov\/tools\/impact_framework.cfm (accessed 27 September 2021)."},{"key":"bibr89-13524585211059766","doi-asserted-by":"publisher","DOI":"10.1097\/MLR.0000000000000683"}],"container-title":["Multiple Sclerosis Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/13524585211059766","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/13524585211059766","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/13524585211059766","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T04:08:10Z","timestamp":1777694890000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/13524585211059766"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,1]]},"references-count":89,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["10.1177\/13524585211059766"],"URL":"https:\/\/doi.org\/10.1177\/13524585211059766","relation":{},"ISSN":["1352-4585","1477-0970"],"issn-type":[{"value":"1352-4585","type":"print"},{"value":"1477-0970","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,1]]}}}